Discovery of human autophagy initiation kinase ULK1 inhibitors by multi-directional in silico screening strategies

References

• Casás-Selves M, DeGregori J. How cancer shapes evolution and how evolution shapes cancer. Evolution. 2011;4:624.
   PubMedGoogle Scholar
• Ferlay J, Colombet M, Soerjomataram I. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2018;144:1941–1953.
   PubMed Web of Science ®Google Scholar
• Senapati S, Mahanta AK, Kumar S, et al. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3:7.
   PubMed Web of Science ®Google Scholar
• Steichen SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci. 2013;48:416–427.
   PubMed Web of Science ®Google Scholar
• Sun Y, Peng ZL. Programmed cell death and cancer. Postgrad Med J. 2009;85:134–140.
   PubMed Web of Science ®Google Scholar
• Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17:528.
   PubMed Web of Science ®Google Scholar
• Bhutia SK, Mukhopadhyay S, Sinha N, et al. Autophagy: cancer's friend or foe? Adv Cancer Res. 2013;118:61–95.
   PubMed Web of Science ®Google Scholar
• Gewirtz DA. The four faces of autophagy: implications for cancer therapy. Cancer Res. 2014;74:647–651.
   PubMed Web of Science ®Google Scholar
• Yang ZJ, Chee CE, Huang S, et al. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther. 2011;10:1533–1541.
   PubMed Web of Science ®Google Scholar
• Rebecca VW, Amaravadi RK. Emerging strategies to effectively target autophagy in cancer. Oncogene. 2016;35:1.
   PubMed Web of Science ®Google Scholar
• De Donato M, Righino B, Filippetti F, et al. Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6. Sci Rep. 2018;8:16047.
   PubMed Web of Science ®Google Scholar
• Goyal S, Jamal S, Grover A, et al. Drug discovery: an in silico approach. In: Shanker A, editor. Bioinformatics: sequences, structures, phylogeny. New York: Springer; 2018. p. 307–328.
   Google Scholar
• Zhang G, Xing J, Wang Y, et al. Discovery of novel inhibitors of indoleamine 2,3-dioxygenase 1 through structure-based virtual screening. Front Pharmacol. 2018;9:277.
   PubMed Web of Science ®Google Scholar
• Kitchen DB, Decornez H, Furr JR, et al. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004;3:935.
   PubMed Web of Science ®Google Scholar
• Cheng T, Li Q, Zhou Z, et al. Structure-based virtual screening for drug discovery: a problem-centric review. Aaps J. 2012;14:133–141.
   PubMed Web of Science ®Google Scholar
• Drwal MN, Griffith R. Combination of ligand- and structure-based methods in virtual screening. Drug Discov Today Technol. 2013;10:e395–e401.
   PubMedGoogle Scholar
• Wilson GL, Lill MA. Integrating structure-based and ligand-based approaches for computational drug design. Future Med Chem. 2011;3:735–750.
   PubMed Web of Science ®Google Scholar
• Svensson F, Karlén A, Sköld C. Virtual screening data fusion using both structure- and ligand-based methods. J Chem Inf Model. 2012;52:225–232.
   PubMed Web of Science ®Google Scholar
• Borhani DW, Shaw DE. The future of molecular dynamics simulations in drug discovery. J Comput Aided Mol Des. 2012;26:15
   PubMed Web of Science ®Google Scholar
• Lazarus MB, Novotny CJ, Shokat KM. Structure of the human autophagy initiating kinase ULK1 in complex with potent inhibitors. ACS Chem Biol. 2015;10:257–261.
   PubMed Web of Science ®Google Scholar
• Pasquier B. Autophagy inhibitors. Cell Mol Life Sci. 2016;73:985–1001.
   PubMed Web of Science ®Google Scholar
• Egan DF, Chun MGH, Vamos M, et al. Small molecule inhibition of the autophagy kinase ULK1 and identification of ULK1 substrates. Mol Cell. 2015;59:285–297.
   PubMed Web of Science ®Google Scholar
• Petherick KJ, Conway OJ, Mpamhanga C, et al. Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy. J Biol Chem. 2015;290:11376–11383.
   PubMed Web of Science ®Google Scholar
• Sastry GM, Adzhigirey M, Day T, et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des. 2013;27:221–234.
   PubMed Web of Science ®Google Scholar
• Greenwood JR, Calkins D, Sullivan AP, et al. Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution. J Comput Aided Mol Des. 2010;24:591–604.
   PubMed Web of Science ®Google Scholar
• Prabhu S, Vijayakumar S, Manogar P, et al. Homology modeling and molecular docking studies on Type II diabetes complications reduced PPARγ receptor with various ligand molecules. Biomed Pharmacother. 2017;92:528–535.
   PubMed Web of Science ®Google Scholar
• Dixon SL, Smondyrev AM, Knoll EH, et al. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des. 2006;20:647–671.
   PubMed Web of Science ®Google Scholar
• Sharma S, Basu A, Agrawal RK. Pharmacophore modeling and docking studies on some nonpeptide-based caspase-3 inhibitors. Biomed Res Int. 2013;2013:1.
   Web of Science ®Google Scholar
• Halgren TA. Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model. 2009;49:377–389.
   PubMed Web of Science ®Google Scholar
• Nagamani S, Muthusamy K, Marshal JJ. E-pharmacophore filtering and molecular dynamics simulation studies in the discovery of potent drug-like molecules for chronic kidney disease. J Biomol Struct Dyn. 2016;34:2233–2250.
   PubMed Web of Science ®Google Scholar
• Sabitha K, Rajkumar T. Identification of small molecule inhibitors against UBE2C by using docking studies. Bioinformation. 2012;8:1047.
   PubMedGoogle Scholar
• Reddy KK, Singh SK, Tripathi SK, et al. Shape and pharmacophore-based virtual screening to identify potential cytochrome P450 sterol 14α-demethylase inhibitors. J Recept Signal Transduct Res. 2013;33:234–243.
   PubMed Web of Science ®Google Scholar
• Halgren TA, Murphy RB, Friesner RA, et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 2004;47:1750–1759.
   PubMed Web of Science ®Google Scholar
• Friesner RA, Murphy RB, Repasky MP, et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem. 2006;49:6177–6196.
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455–461.
   PubMed Web of Science ®Google Scholar
• Schneidman-Duhovny D, Inbar Y, Nussinov R, et al. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res. 2005;33:W363–W367.
   PubMed Web of Science ®Google Scholar
• Tang D, Chen K, Huang L, et al. Pharmacokinetic properties and drug interactions of apigenin, a natural flavone. Expert Opin Drug Metab Toxicol. 2017;13:323–330.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xing J, Xu Y, et al. In silico ADME/T modelling for rational drug design. Q Rev Biophys. 2015;48:488–515.
   PubMed Web of Science ®Google Scholar
• Parasuraman S. Prediction of activity spectra for substances. J Pharmacol Pharmacother. 2011;2:52.
   PubMedGoogle Scholar
• Goel RK, Singh D, Lagunin A, et al. PASS-assisted exploration of new therapeutic potential of natural products. Med Chem Res. 2011;20:1509–1514.
   Web of Science ®Google Scholar
• Tam NM, Vu KB, Vu VV, et al. Influence of various force fields in estimating the binding affinity of acetylcholinesterase inhibitors using fast pulling of ligand scheme. Chem Phys Lett. 2018;701:65–71.
   Web of Science ®Google Scholar
• Lemkul JA, Allen WJ, Bevan DR. Practical considerations for building GROMOS-compatible small-molecule topologies. J Chem Inf Model. 2010;50:2221–2235.
   PubMed Web of Science ®Google Scholar
• Schüttelkopf AW, Van Aalten DM. PRODRG: a tool for high-throughput crystallography of protein–ligand complexes. Acta Crystallogr D Biol Crystallogr. 2004;60:1355–1363.
   PubMed Web of Science ®Google Scholar
• Li J, Zhu X, Yang C, et al. Characterization of the binding of angiotensin II receptor blockers to human serum albumin using docking and molecular dynamics simulation. J Mol Model. 2010;16:789–798.
   PubMed Web of Science ®Google Scholar
• Sastry GM, Dixon SL, Sherman W. Rapid shape-based ligand alignment and virtual screening method based on atom/feature-pair similarities and volume overlap scoring. J Chem Inf Model. 2011;51:2455–2466.
   PubMed Web of Science ®Google Scholar
• Yamashita F, Hashida M. In silico approaches for predicting ADME properties of drugs. Drug Metab Pharmacokinet. 2004;19:327–338.
   PubMedGoogle Scholar
• Sun WY, Kim HM, Koo JS. Expression of autophagy-related proteins in metastatic breast cancer of different site. Int J Clin Exp Pathol. 2016;9:7040–7049.
   Web of Science ®Google Scholar
• Lagunin A, Stepanchikova A, Filimonov D, et al. PASS: prediction of activity spectra for biologically active substances. Bioinformatics. 2000;16:747–748.
   PubMed Web of Science ®Google Scholar
• Laskowski RA, Swindells MB. LigPlot+: multiple ligand–protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51:2778–2786.
   PubMed Web of Science ®Google Scholar
• Egan D, Kim J, Shaw RJ, et al. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy. 2011;7:643–644.
   PubMed Web of Science ®Google Scholar
• Papinski D, Kraft C. Regulation of autophagy by signaling through the Atg1/ULK1 complex. J Mol Biol. 2016;428:1725–1741.
   PubMed Web of Science ®Google Scholar
• Boulahjar R, Ouach A, Matteo C, et al. Novel tetrahydropyrido [1, 2-a] isoindolone derivatives (valmerins): potent cyclin-dependent kinase/glycogen synthase kinase 3 inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts. J Med Chem. 2012;55:9589–9606.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Nocentini A, Al-Rashood ST, et al. Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer. Bioorg Chem. 2018;81:425–432.
   PubMed Web of Science ®Google Scholar
• Hartmann Rolf W, Batzl C. Aromatase inhibitors. Synthesis and evaluation of mammary tumor inhibiting activity of 3-alkylated 3-(4-aminophenyl) piperidine-2, 6-diones. J Med Chem. 1986;29:1362–1369.
   PubMed Web of Science ®Google Scholar